Patrick S. Ward

Using Biomechanical Devices in Elite Baseball Pitchers: A Preliminary Feasibility Study

Garrett Fernandez, Kristen F. Nicholson, Franco M. Impellizzeri, Patrick S. Ward et autres

us (code pays fourni par la source)

Is There a Relationship Between Grip Strength and Injuries in Professional Baseball Players? Letter to the Editor

Justin M. Losciale, Scot Morrison, Chad E. Cook, Patrick S. Ward

Using Biomechanical Devices in Elite Baseball Pitchers: A Preliminary Feasibility Study

Chelsea Martin, Kelly R. Evenson, Justin B. Moore, Stephen W. Marshall et autres

us, au, ca, gb (code pays fourni par la source)

Training-Load Management Ambiguities and Weak Logic: Creating Potential Consequences in Sport Training and Performance

Stephen West, Ian Shrier, Franco M. Impellizzeri, Jo Clubb et autres

ca, gb, au, us (code pays fourni par la source)

The mitochondrial calcium uniporter transports Ca 2+ via a ligand-relay mechanism

Connie Chan, Chen‐Ching Yuan, Jason G. McCoy, Patrick S. Ward et autres

us (code pays fourni par la source)

Supplementary Methods, Figure Legends from Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia

Alan H. Shih, Cem Meydan, Kaitlyn Shank, Francine E. Garrett-Bakelman et autres

Supplementary Tables S1 - S2 from Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia

Alan H. Shih, Cem Meydan, Kaitlyn Shank, Francine E. Garrett-Bakelman et autres

Supplementary Figures S1 - S9 from Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia

Alan H. Shih, Cem Meydan, Kaitlyn Shank, Francine E. Garrett-Bakelman et autres

Supplementary Figures S1 - S9 from Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia

Alan H. Shih, Cem Meydan, Kaitlyn Shank, Francine E. Garrett-Bakelman et autres

Supplementary Methods, Figure Legends from Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia

Alan H. Shih, Cem Meydan, Kaitlyn Shank, Francine E. Garrett-Bakelman et autres

Supplementary Tables S1 - S2 from Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia

Alan H. Shih, Cem Meydan, Kaitlyn Shank, Francine E. Garrett-Bakelman et autres

Data from Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia

Alan H. Shih, Cem Meydan, Kaitlyn Shank, Francine E. Garrett-Bakelman et autres